与爆发性1型糖尿病的发展相关的药物类别:使用FDA不良事件报告系统数据库进行回顾性分析
Yang Zhou1, Yupeng Chen1, Shan Zhang1
1Department of Endocrinology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Expert opinion on drug safety
|January 11, 2025
概括
某些药物,包括免疫检查点抑制剂和精神病药物,与1型糖尿病 (FT1DM) 的高风险有关. 对于服用这些药物的患者,建议加强药物监测和葡萄糖监测.
科学领域:
- 药物监督 药物监督 药物监督
- 内分泌学 在内分泌学.
- 药品安全 药品安全
背景情况:
- 1型糖尿病 (FT1DM) 是一种严重的1型糖尿病,发病速度快,胰岛素分泌失败.
- 新出现的证据表明FT1DM与特定药物剂之间存在潜在联系.
- 进一步的调查对于了解FT1DM与药物相关的风险至关重要.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 数据库识别与FT1DM风险增加相关的药物.
- 分析与FT1DM相关的不良事件报告模式.
- 为改善药物安全性和减少FT1DM发病率提供见解.
主要方法:
- 对FAERS数据从2013年到2023年的回顾性分析.
- 使用文本挖掘对药物名称的标准化.
- 使用ROR,PRR,BCPNN和MGPS等统计方法评估安全信号.
主要成果:
- 确定了706例FT1DM病例,老年男性患病率更高.
- 十九种药物与FT1DM风险有关,包括免疫检查点抑制剂 (例如,尼沃卢马布,伊皮利穆马布),伦瓦提尼布,埃里布林以及某些精神病,抗感染和代谢药物.
- 确定的特定药物包括阿托莫克西丁,卡巴马泽平,拉莫特里金,硫甲醇,三甲胺,阿莫西林,达帕格利弗洛辛,西塔格利普丁,酸,酸和阿洛普里诺.
结论:
- 这项研究确定了几种可能触发FT1DM的药物.
- 强调了对这些药物的药监督的重要性.
- 建议在服用这些药物的患者中保持警的葡萄糖监测,以减轻风险.
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...